With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...
New research finds that binge-eating disorder symptoms may persist longer than once believed, finding 61 percent and 45 percent of individuals still experienced binge-eating disorder 2.5 and 5 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results